Defining and analysing symptom palliation in cancer clinical trials: a deceptively difficult exercise
about
Evaluation of safety and efficacy of gefitinib ('iressa', zd1839) as monotherapy in a series of Chinese patients with advanced non-small-cell lung cancer: experience from a compassionate-use programmeThe analysis, interpretation, and presentation of quality of life data.Quality-of-life evaluation for advanced non-small-cell lung cancer: a comparison between vinorelbine plus gemcitabine followed by docetaxel versus paclitaxel plus carboplatin regimens in a randomized trial: Japan Multinational Trial Organization LC0BTS randomised feasibility study of active symptom control with or without chemotherapy in malignant pleural mesothelioma: ISRCTN 54469112Symptom control.Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer.A prospective, randomised study to compare two palliative radiotherapy schedules for non-small-cell lung cancer (NSCLC).Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer--a randomized trial with quality of life as the primary outcome. UK NSCLC Gemcitabine Group. Non-Small Cell Lung CancerActive symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trialNCIC Clinical Trials Group experience of employing patient-reported outcomes in clinical trials: an illustrative study in a palliative setting.Portomesenteric Venous Stenting for Palliation of Ascites and Variceal Bleeding Caused by Prehepatic Portal Hypertension.
P2860
Q24805211-D85A4EF1-C123-482A-8E4C-3ADCE6BB7375Q30913610-0C09F825-DC77-424E-9E42-F9074F5D4A9AQ33995141-123ECBDE-1397-4B42-99BC-6261145E59CAQ35536471-7559F776-37E9-4DD8-AABC-9E7C91CA9E23Q35553856-28AF3A29-DE1A-47A0-932F-4FF665BD05AFQ36612331-68E5977E-F5C7-4052-AFF5-52A02EA98B0DQ36616511-3D4E7846-19F9-4DBE-82B9-9FC9BABD251EQ36642218-FF515B54-6EBF-45A0-AC0B-C17B9C60BD6AQ36727434-C0B379BB-A89F-4A58-B617-4E70C1CC1BF5Q37763136-1ED82F51-0E0D-4C20-97C4-7AC5DFF1178AQ48334725-78397335-CB13-41CD-B499-ED723B4B49BE
P2860
Defining and analysing symptom palliation in cancer clinical trials: a deceptively difficult exercise
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Defining and analysing symptom ...... deceptively difficult exercise
@en
Defining and analysing symptom ...... eceptively difficult exercise.
@nl
type
label
Defining and analysing symptom ...... deceptively difficult exercise
@en
Defining and analysing symptom ...... eceptively difficult exercise.
@nl
prefLabel
Defining and analysing symptom ...... deceptively difficult exercise
@en
Defining and analysing symptom ...... eceptively difficult exercise.
@nl
P2093
P2860
P356
P1476
Defining and analysing symptom ...... deceptively difficult exercise
@en
P2093
Girling DJ
Stephens RJ
P2860
P2888
P304
P356
10.1038/SJ.BJC.6690085
P407
P577
1999-02-01T00:00:00Z